CURRENT / OASIS-7
- 18,000 participants
- 7 sites in New Zealand
- 600-800 sites globally
Randomised, multinational, double-blind study, comparing a high loading dose regimen of clopidogrel versus standard dose in patients with unstable angina or non-ST segment elevation myocardial infarction managed with an early invasive strategy
This is a phase III, multinational, multicentre, randomised, factorial design, parallel-group study comparing 2 regimens of clopidogrel (high versus standard dose) in a double-blind fashion and 2 regimens of aspirin (high versus low dose) in an open-label fashion in participants with symptoms of acute coronary disease who undergo a percutaneous coronary intervention as early as possible within 24 hours.
For further information, please visit http://clinicaltrials.gov/ct2/show/NCT00335452?term=NCT00335452&rank=1